JACC: Case Reports (Jun 2023)

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement

  • Choon Ta Ng, MBBS,
  • Hilda M. Gonzalez Bonilla, MD,
  • Ian Chang, MD,
  • M. Tun Aung, MD,
  • Jennifer J. Gile, MD,
  • Naveen L. Pereira, MD,
  • Jose C. Villasboas Bisneto, MD,
  • Patrick B. Johnston, MD,
  • Hector R. Villarraga, MD,
  • Martin G. Rodriguez-Porcel, MD,
  • Grace Lin, MD,
  • Yi Lin, MD, PhD,
  • Joerg Herrmann, MD

Journal volume & issue
Vol. 15
p. 101840

Abstract

Read online

Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the management of aggressive hematologic malignancies. However, its role in patients with lymphoma and cardiac metastasis or cardiomyopathy remains undefined due to potentially life-threatening complications such as ventricular rupture, cardiac tamponade, and circulatory failure. We present a case series of patients with lymphoma and cardiomyopathy or cardiac metastasis managed with chimeric antigen receptor T-cell therapy. (Level of Difficulty: Advanced.)

Keywords